analyst
NM
NASDAQ · NMTC
NeuroOne Medical Technologies Corporation
Healthcare · Medical - Devices
$1.50
Down-$0.06 (-3.85%)
Updated Sep 15, 2026, 2:58 AM
SID Score
5.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 29.33M
- P/E ratio
- -5.35
- Dividend yield
- 0.00%
- 52-week range
- $0.70 – $5.40
- Volume
- 38.79K
- Avg. volume
- 334.87K
Price performance
NMTC price history
1M range · 20 trading sessions · Daily adjusted prices
NMTC closed at $1.50 after 20 trading sessions, down 20.21% for the selected period.
- Last close
- $1.50
- Period change
- -20.21%
- Period low
- $1.50
- Period high
- $2.18
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 14, 2026 | $1.57 | $1.58 | $1.50 | $1.50 | 38.79K |
| Sep 11, 2026 | $1.59 | $1.60 | $1.55 | $1.56 | 64.23K |
| Sep 10, 2026 | $1.65 | $1.67 | $1.56 | $1.58 | 225.22K |
| Sep 9, 2026 | $1.71 | $1.725 | $1.63 | $1.66 | 99.7K |
| Sep 8, 2026 | $1.68 | $1.73 | $1.58 | $1.69 | 275.01K |
| Sep 4, 2026 | $1.65 | $1.66 | $1.57 | $1.62 | 81.1K |
| Sep 3, 2026 | $1.68 | $1.73 | $1.6201 | $1.66 | 32.34K |
| Sep 2, 2026 | $1.60 | $1.80 | $1.5802 | $1.67 | 203.87K |
| Sep 1, 2026 | $1.67 | $1.72 | $1.60 | $1.61 | 72.18K |
| Aug 31, 2026 | $1.70 | $1.81 | $1.6161 | $1.70 | 259.33K |
| Aug 28, 2026 | $1.89 | $1.96 | $1.70 | $1.77 | 519.44K |
| Aug 27, 2026 | $2.16 | $3.49 | $1.89 | $1.98 | 13.92M |
| Aug 26, 2026 | $2.16 | $2.1656 | $2.00 | $2.00 | 10.4K |
| Aug 25, 2026 | $2.1602 | $2.20 | $2.10 | $2.16 | 24.19K |
| Aug 24, 2026 | $2.00 | $2.24 | $1.90 | $2.14 | 58.71K |
| Aug 21, 2026 | $2.15 | $2.1503 | $2.01 | $2.03 | 35.34K |
| Aug 20, 2026 | $2.18 | $2.3099 | $2.15 | $2.15 | 59.25K |
| Aug 19, 2026 | $1.88 | $2.37 | $1.865 | $2.18 | 85.86K |
| Aug 18, 2026 | $1.90 | $2.0899 | $1.82 | $1.88 | 47.31K |
| Aug 17, 2026 | $1.94 | $1.9756 | $1.85 | $1.88 | 30.47K |
Latest NMTC news
The latest Smart Investors Daily articles mentioning NMTC.
Stock researchCompany · Forecast
Loading stock research…